Cambridge Investment Research Advisors’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$526K Sell
19,056
-1,824
-9% -$50.3K ﹤0.01% 2507
2025
Q1
$592K Sell
20,880
-2,060
-9% -$58.4K ﹤0.01% 2267
2024
Q4
$954K Buy
22,940
+2,064
+10% +$85.8K ﹤0.01% 1914
2024
Q3
$1.4M Sell
20,876
-3,574
-15% -$239K ﹤0.01% 1608
2024
Q2
$2.9M Sell
24,450
-1,336
-5% -$159K 0.01% 1051
2024
Q1
$2.75M Buy
25,786
+2,605
+11% +$278K 0.01% 1080
2023
Q4
$2.31M Sell
23,181
-6,329
-21% -$629K 0.01% 1119
2023
Q3
$3.05M Sell
29,510
-10,434
-26% -$1.08M 0.01% 915
2023
Q2
$4.85M Sell
39,944
-15,927
-29% -$1.94M 0.02% 678
2023
Q1
$8.58M Buy
55,871
+14,560
+35% +$2.24M 0.04% 415
2022
Q4
$7.42M Buy
41,311
+2,797
+7% +$502K 0.04% 442
2022
Q3
$4.55M Sell
38,514
-1,779
-4% -$210K 0.03% 612
2022
Q2
$5.76M Buy
40,293
+6,108
+18% +$873K 0.03% 527
2022
Q1
$5.89M Sell
34,185
-4,064
-11% -$700K 0.03% 567
2021
Q4
$9.72M Sell
38,249
-20,059
-34% -$5.09M 0.04% 388
2021
Q3
$22.4M Buy
58,308
+18,296
+46% +$7.04M 0.11% 189
2021
Q2
$9.4M Sell
40,012
-11,721
-23% -$2.75M 0.05% 388
2021
Q1
$6.77M Buy
51,733
+458
+0.9% +$60K 0.04% 459
2020
Q4
$5.36M Sell
51,275
-18,720
-27% -$1.96M 0.03% 505
2020
Q3
$4.95M Buy
69,995
+6,255
+10% +$443K 0.03% 467
2020
Q2
$4.09M Sell
63,740
-171,556
-73% -$11M 0.03% 505
2020
Q1
$7.05M Sell
235,296
-109,295
-32% -$3.27M 0.07% 272
2019
Q4
$6.74M Sell
344,591
-49,810
-13% -$974K 0.05% 363
2019
Q3
$6.28M Buy
+394,401
New +$6.28M 0.06% 335